David Ludvigson is a financial and operating executive with over 35 years of international experience in life sciences and technology companies including IDEC Pharmaceuticals, Matrix Pharmaceutical, Nanogen, and MIPS Computer Systems.
Mr Ludvigson is the chief executive of Nanomix, a point-of-care diagnostic medical device company.
His experience over 15 years in the diagnostics arena has led new product efforts from concept to market launch. He has concluded transactions including acquisitions, corporate partnerships, technology and intellectual property licensing agreements, and OEM relationships.
His financing experience includes venture capital, corporate, mezzanine, lease, bank credit line, LBO, IPO and secondary public sources.